These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 15129579

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Oral contraceptives and venous thromboembolism.
    Savage RL.
    N Z Med J; 1997 Mar 28; 110(1040):109. PubMed ID: 9137318
    [No Abstract] [Full Text] [Related]

  • 44. Post-menopausal hormone replacement therapy (cont'd): risk-benefit balance in the hot seat.
    Prescrire Int; 2004 Jun 28; 13(71):106-9. PubMed ID: 15233153
    [Abstract] [Full Text] [Related]

  • 45. Hormonal contraception and venous thromboembolic risk in midlife women.
    Lidegaard Ø.
    Maturitas; 2013 Jan 28; 74(1):1-2. PubMed ID: 23098858
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. [Drugs and venous thromboembolism].
    Lacut K, Mottier D, Pottier P.
    Rev Pneumol Clin; 2008 Dec 28; 64(6):290-7. PubMed ID: 19084208
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Postmenopausal hormone therapy in clinical perspective.
    Hodis HN, Mack WJ.
    Menopause; 2007 Dec 28; 14(5):944-57. PubMed ID: 17353803
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. [The risk of venous thromboembolism in women during hormone replacement therapy].
    Zeltzer D, Shapira I, Berliner S.
    Harefuah; 1999 Aug 28; 137(3-4):124-6. PubMed ID: 10959301
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Sex hormones and venous thromboembolism - from contraception to hormone replacement therapy.
    Beyer-Westendorf J, Bauersachs R, Hach-Wunderle V, Zotz RB, Rott H.
    Vasa; 2018 Oct 28; 47(6):441-450. PubMed ID: 30008249
    [Abstract] [Full Text] [Related]

  • 55. Individualising hormone replacement therapy.
    Attilakos G, Wardle PG.
    Practitioner; 2002 May 28; 246(1634):295-8, 302, 305 passim. PubMed ID: 12043347
    [No Abstract] [Full Text] [Related]

  • 56. [Hormone replacement therapy in postmenopausal women: all the treatments are not the same].
    Ribot C, Trémollieres F.
    Gynecol Obstet Fertil; 2007 May 28; 35(5):388-97. PubMed ID: 17392010
    [Abstract] [Full Text] [Related]

  • 57. Thromboembolism during hormone therapy in Japanese women.
    Adachi T, Sakamoto S.
    Semin Thromb Hemost; 2005 Jun 28; 31(3):272-80. PubMed ID: 16052396
    [Abstract] [Full Text] [Related]

  • 58. Age and menopausal effects of hormonal birth control and hormone replacement therapy in relation to breast cancer risk.
    Shantakumar S, Terry MB, Paykin A, Teitelbaum SL, Britton JA, Moorman PG, Kritchevsky SB, Neugut AI, Gammon MD.
    Am J Epidemiol; 2007 May 15; 165(10):1187-98. PubMed ID: 17337757
    [Abstract] [Full Text] [Related]

  • 59. Health risks after cessation of postmenopausal hormone therapy.
    Pines A, Sturdee D, Birkhäuser M, International Menopause Society.
    Climacteric; 2008 Jun 15; 11(3):179-80. PubMed ID: 18568782
    [No Abstract] [Full Text] [Related]

  • 60. [Ocular complications of hormonal treatments: oral contraception and menopausal hormonal replacement therapy].
    Glacet-Bernard A, Kuhn D, Soubrane G.
    Contracept Fertil Sex; 1999 Apr 15; 27(4):285-90. PubMed ID: 10349771
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.